Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Finished Goods (2016 - 2019)

Historic Finished Goods for Aptevo Therapeutics (APVO) over the last 5 years, with Q4 2019 value amounting to $3.7 million.

  • Aptevo Therapeutics' Finished Goods rose 44666.67% to $3.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $3.7 million, marking a year-over-year increase of 44666.67%. This contributed to the annual value of $3.7 million for FY2019, which is 44666.67% up from last year.
  • Latest data reveals that Aptevo Therapeutics reported Finished Goods of $3.7 million as of Q4 2019, which was up 44666.67% from $1.4 million recorded in Q3 2019.
  • In the past 5 years, Aptevo Therapeutics' Finished Goods ranged from a high of $9.1 million in Q4 2015 and a low of $64000.0 during Q2 2018
  • In the last 5 years, Aptevo Therapeutics' Finished Goods had a median value of $1.2 million in 2017 and averaged $2.8 million.
  • As far as peak fluctuations go, Aptevo Therapeutics' Finished Goods tumbled by 9895.01% in 2018, and later soared by 67031.25% in 2019.
  • Aptevo Therapeutics' Finished Goods (Quarter) stood at $9.1 million in 2015, then plummeted by 97.83% to $197000.0 in 2016, then soared by 148.73% to $490000.0 in 2017, then skyrocketed by 37.76% to $675000.0 in 2018, then soared by 446.67% to $3.7 million in 2019.
  • Its Finished Goods stands at $3.7 million for Q4 2019, versus $1.4 million for Q3 2019 and $493000.0 for Q2 2019.